Bayer Inc. appoints Ryan Engel as new Country Division Head for Consumer Health division in Canada

Mississauga, August 15, 2024 – Bayer Inc. (Bayer) is pleased to announce the appointment of Ryan Engel as Country Division Head (CDH) of the Consumer Health division in Canada.


Engel brings ten years of marketing experience at Bayer, where he led Bayer’s Consumer Health brands. Prior to joining Bayer in 2015, Ryan held various brand management and sales roles across the Pharmaceutical, Consumer Packaged Goods and the OTC industries.


“Bayer’s Consumer Health business has meaningful brands that meet Canadians self-care needs through innovation and access,” said Ryan Engel, CDH, Consumer Health for Bayer in Canada. “I am excited to work with the incredible Canadian team to continue the strong legacy of delivering solutions for consumers and customers across the country.”

 

As a brand architect, Engel has been recognized for his strategic approach and dedication to driving customer-focused solutions that deliver results. With extensive retail and OTC expertise, he has a proven track record in brand innovation and successful market expansion.


Engel succeeds Elizabeth Beemer, who will be supporting the transition until her retirement from Bayer, effective September 30.


About Bayer


Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros. For more information, go to www.bayer.ca

 

Contact for media inquiries:

Communications Department

Bayer Inc.

mediacanada@bayer.com

 

Find more information at www.bayer.ca